DNA Topoisomerase IIα and -β in Ovarian Cancer
Author Information
Author(s): Withoff S, Zee A G J van der, Jong S de, Hollema H, Smit E F, Mulder N H, Vries E G E de
Primary Institution: University Hospital Groningen, Groningen, The Netherlands
Hypothesis
To study DNA topoisomerase IIα (Topo-IIα) and -β expression and regulation in human ovarian cancer.
Conclusion
The study suggests that Topo-IIα and Topo-IIβ protein levels are up-regulated in ovarian cancer, indicating that Topo-IIβ may be a target for chemotherapy.
Supporting Evidence
- The study investigated 15 ovarian tumor samples for Topo-IIα and -β expression.
- Correlations were found between Topo-IIα mRNA and protein levels.
- Topo-IIβ protein levels correlated better with Topo-II activity than Topo-IIα.
Takeaway
The researchers looked at proteins in ovarian cancer and found that two specific proteins are more active in cancer, which could help in treating it.
Methodology
The study used Northern blotting, quantitative RT-PCR, Western blotting, and a decatenation assay to analyze mRNA and protein levels.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website